Cocrystal Pharma Announces Participation in Virtual Investor Events
BOTHELL, Wash., Jan. 26, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq:COCP) announces the participation of James Martin, co-CEO and CFO, in the following virtual investment community events:
Related news for (COCP)
- Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- 24/7 Market News Snapshot 12 September, 2025 – Cocrystal Pharma, Inc. Common Stock (NASDAQ:COCP)
- Biotech Breakouts & Bitcoin Bets
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/12/25 08:00 AM
- Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
